Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for Opioid Withdrawal
NCT03017430Phase 4Completed
- Sponsor
- Bekhterev National Medical Research Center for Psychiatry and Neurology
- Start
- Jan 2014
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pregabalin in opioid withdrawal syndrome (OWS), sponsored by Bekhterev National Medical Research Center for Psychiatry and Neurology. Started Jan 2014; status: completed.
02
Drugs
pregabalin
03
Conditions
opioid withdrawal syndrome (OWS)
Beyond the preview
Go deeper on NCT03017430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03017430.